Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction.

Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: Print Cited Medium: Internet ISSN: 1755-5922 (Electronic) Linking ISSN: 17555914 NLM ISO Abbreviation: Cardiovasc Ther Subsets: MEDLINE

Publication: 2019- : [London, United Kingdom] : Hindawi
Original Publication: Oxford : Wiley-Blackwell, c2008-c2018.

Anti-Inflammatory Agents/*pharmacology ; Atorvastatin/*pharmacology ; Heart/*innervation ; Macrophage Activation/*drug effects ; Macrophages, Peritoneal/*drug effects ; Myocardial Infarction/*drug therapy ; Myocardium/*immunology ; Sympathetic Nervous System/*drug effects; Animals ; Anti-Arrhythmia Agents/pharmacology ; Arginase/genetics ; Arginase/metabolism ; Cells, Cultured ; Disease Models, Animal ; GAP-43 Protein/metabolism ; Interleukin-1beta/genetics ; Interleukin-1beta/metabolism ; Macrophages, Peritoneal/immunology ; Macrophages, Peritoneal/metabolism ; Male ; Myocardial Infarction/immunology ; Myocardial Infarction/physiopathology ; Myocardium/metabolism ; Myocardium/pathology ; Nerve Growth Factor/genetics ; Nerve Growth Factor/metabolism ; Nitric Oxide Synthase Type II/genetics ; Nitric Oxide Synthase Type II/metabolism ; Phenotype ; Rats, Wistar ; Sympathetic Nervous System/metabolism ; Sympathetic Nervous System/physiopathology ; Tachycardia, Ventricular/immunology ; Tachycardia, Ventricular/physiopathology ; Tachycardia, Ventricular/prevention & control ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Tyrosine 3-Monooxygenase/metabolism ; Ventricular Fibrillation/immunology ; Ventricular Fibrillation/physiopathology ; Ventricular Fibrillation/prevention & control

Objectives: Inflammation after myocardial infarction (MI) causes cardiac nerve sprouting and consequent ventricular arrhythmias (VAs). Macrophages, as major immune cells, are involved in the entire inflammation response process and serve as a link between inflammation and sympathetic hyperinnervation by regulating nerve growth factor (NGF) expression. Accumulating evidence shows that statins possess antiarrhythmogenic properties, and the aim of this study was to explore the mechanism by which atorvastatin ameliorates cardiac sympathetic nerve sprouting via regulating macrophage polarization.
Methods: Rat models of MI were created by ligating the left coronary artery. MI-operated rats received either atorvastatin or phosphate-buffered saline for 7 days. Immunohistochemical analyses and immunofluorescence staining were used to analyze macrophage infiltration after MI and to detect the distribution and density of growth-associated protein-43 (GAP-43) and tyrosine hydroxylase (TH) in nerve fibers in peri-infarct zones after MI. The polarity of the macrophages that were obtained from the rat peritoneal cavity was examined via flow cytometry. The protein levels of NGF were detected via Western blot analysis, and the concentrations of NGF in the supernatants were determined via enzyme-linked immunosorbent assay. The mRNA levels of NGF, inducible nitric oxide synthase (iNOS), Arginase-1 (Arg1), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) were examined by quantitative real-time polymerase chain reaction. The association between VAs and MI was evaluated using programmed electrophysiological stimulation.
Results: Macrophages were successfully induced to the M1 (classically activated) and M2 (alternatively activated) phenotypes by stimulation with lipopolysaccharide and interferon-γ (LPS + IFN-γ) and interleukin-4 (IL-4), respectively. Atorvastatin markedly downregulated IL-1β, TNF-α, iNOS, and NGF and upregulated Arg1, shifting the macrophage phenotype from M1 to M2. Moreover, atorvastatin significantly reduced TH levels and the density of GAP-43-positive nerve fibers and decreased inducible VAs.
Conclusion: Atorvastatin effectively ameliorated cardiac sympathetic nerve remodeling and prevented VAs after MI by significantly downregulating the expression of NGF, IL-1β, and TNF-α via together with the augmentation of M2 macrophage.
(© 2016 John Wiley & Sons Ltd.)

Keywords: Atorvastatin; Inflammation; Macrophage polarization; Myocardial infarction; Sympathetic nerve

0 (Anti-Arrhythmia Agents)
0 (Anti-Inflammatory Agents)
0 (GAP-43 Protein)
0 (IL1B protein, rat)
0 (Interleukin-1beta)
0 (Tumor Necrosis Factor-alpha)
9061-61-4 (Nerve Growth Factor)
A0JWA85V8F (Atorvastatin)
EC 1.14.13.39 (Nitric Oxide Synthase Type II)
EC 1.14.13.39 (Nos2 protein, rat)
EC 1.14.16.2 (Tyrosine 3-Monooxygenase)
EC 3.5.3.1 (Arginase)
EC 3.5.3.1 (arginase I, rat)

Date Created: 20160506 Date Completed: 20170206 Latest Revision: 20181202

20240829

10.1111/1755-5922.12193

27149420